In addition, LAM patients with higher MMP-9 expression level had a lower survival rate and a higher risk of receiving lung transplantation (p < 0.03) [6], indicating that the monitoring of MMP-9 can be used to assess the prognosis of LAM. This evidence concerns the gene MMP9 and lymphangioleiomyomatosis.